Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02437617 · ClinicalTrials.gov registry record
Genomic Profiling Assay in Phase I
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 500
- Enrollment target
NCT02437617: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT02437617 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02437617 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
The goal of this research study is to collect and test tumor tissue from patients with advanced cancers that may be enrolled in Phase 1 studies or other treatments. Researchers will study if the results from genetic testing can help researchers determine which therapy may prove more beneficial for a patient in the future.
Interventions
- PROCEDURE Tumor Tissue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2012-07-13 |
| Est. Completion | 2021-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02437617
The ClinicalTrials.gov registry entry for NCT02437617 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tumor Tissue is the first listed.
NCT02437617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02437617 about?
NCT02437617 is a clinical study titled "Genomic Profiling Assay in Phase I". The goal of this research study is to collect and test tumor tissue from patients with advanced cancers that may be enrolled in Phase 1 studies or other treatments. Researchers will study if the results from genetic testing can help researchers determine which therapy may prove more beneficial for a...
What is the current status of trial NCT02437617?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2012-07-13. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT02437617?
The interventions under investigation include: Tumor Tissue (PROCEDURE).
Who is sponsoring clinical trial NCT02437617?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.